Kevin Rakin, Director at ORAMED PHARMACEUTICALS INC. (ORMP), sold 10,000 shares at $9.41 ($94K) on 2022-03-21, disclosed to the SEC on 2022-03-22.
Open-market sale of $94k ORMP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORMP | SELL | 2021-09-20 | $886K | — | Filing → |
| HSGX | BUY | 2014-12-08 | $124K | — | Filing → |
| HSGX | SELL | 2014-12-08 | $187 | — | Filing → |